Articles by Kaitlyn D’Onofrio
An assessment of cumulative social risk may help identify patients with advanced colorectal cancer (CRC) who are less ...
The addition of aprepitant to a regimen to reduce chemotherapy-induced nausea among women was effective in a recent ...
A breath analyzer may be able to identify gastric cancer, a study discovered.
...
Medicaid expansion associated with the Affordable Care Act (ACA) may have improved early diagnosis, enhanced access, and ...
The U.S. Preventative Services Task Force (USPSTF) released draft guidelines recommending that colorectal cancer (CRC) ...
Sarcopenia was an independent risk factor for 90-day morbidity among patients undergoing liver resection for malignant ...
A study evaluated the effect of adjuvant chemotherapy on overall survival in pancreatic cancer patients following ...
Researchers recently reported the results of the randomized, controlled phase 3 KEYNOTE-062 trial, which compared ...
According to the findings of the Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group CLASS02 study, which ...
A new study observed a correlation between newly diagnosed diabetes and recent weight loss and an increased likelihood ...
A phase I/II study examined treatment strategies for patients with pancreatic cancer and peritoneal metastasis. After ...
Researchers recently analyzed the literature to determine the association between whole grain intake and digestive tract ...
A study explored the safety and efficacy of nivolumab to treat patients with advanced refractory biliary tract cancer.
...
A study presented as part of the American Association for Cancer Research virtual meeting found promising results for ...
Blood-based biomarkers may help scientists identify pancreatic cancer at an early stage, a new study found—a ...
A matched cohort study found that patients with any polyps have a greater likelihood of having colorectal cancer, and ...
A new study compared mortality among pediatric and adult colon cancer patients. The researchers concluded that pediatric ...
The Food and Drug Administration granted approval for AstraZeneca and Merck’s Lynparza (olaparib) as a first-line ...
A new study explored outcomes in pancreatic ductal adenocarcinoma by race, questioning whether treatment inequity, tumor ...
A new analysis observed a significant increase in the incidence of and mortality associated with squamous cell carcinoma ...
630 Madison Ave.
Manalapan, NJ 07726
About Column
Contribute Column
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.